R&D
MDS
GMP & PIPELINE
PRODUCT
PUBLICATIONS
INVESTORS
공시정보
재무제표
주가
IR정보
공고
NEWS
PEOPLEBIO
KOREAN
ENGLISH
KOREAN
ENGLISH
R&D
MDS
GMP & PIPELINE
PRODUCT
PUBLICATIONS
INVESTORS
공시정보
재무제표
주가
IR정보
공고
NEWS
PEOPLEBIO
PUBLICATIONS
연구개발 중심의 피플바이오는 꾸준하게 논문을 발표하고 있습니다.
PUBLICATIONS
2021
Plasma amyloid-β oligomerization assay as a pre-screening test for amyloid status
RB. Mofrad, Philip Scheltens, Kim SY, Kang SM, Youn YC, An SSA, Jori Tomassen, Bart N. M. van Berckel, PJ.Visser, Wiesje M. van der Flier & Charlotte E. Teunissen
2021
Development of molecular tools for diagnosis of Alzheimer’s disease that are based on detection of amyloidogenic proteins
KY. Kulichikhin, SA. Fedotov, MS. Rubel, NM. Zalutskaya, AE. Zobnina, OA. Malikova, NG. Neznanov, YO. Chernoff & AA. Rubel
2021
Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET Positivity
Pyun JM, Ryu JS, Lee R, Shim KH, Youn YC, Ryoo NY, Han SW, Park YH, Kang SM, An SSA, Kim SY
2021
Is Korea Prepared for an Alzheimer’s Disease-Modifying Therapy? Assessing the Korean Healthcare System Infrastructure and the Effect of Blood-Based Biomarker Tests
Jun HK, Cho SK, Yoong J, Mattke S
2021
Amyloid Metabolism and Amyloid-Targeting Blood-Based Biomarkers of Alzheimer’s Disease
Pyun JM, Kang MJ, Ryoo NY, Suh JW, Youn YC, Park YH, Kim SY
01
02
03
04
05